SEC Form 4 · accession 0000899243-16-016142
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Sirgo
Officer — President and CEO · Director
Period of report
Mar 16, 2016
Accepted (ET)
Mar 16, 2016 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 16, 2016 | A | 10,100 | $2.63 | A | 1,145,739 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 16, 2016, the Reporting Person purchased an aggregate of 10,100 shares of the Issuer's Common Stock at a weighted average price of $2.63 per share. The highest purchase price for the Common Stock was $2.66 per share and the lowest purchase price was $2.60 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.